Global HMO Children's Milk Powder Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global HMO Children's Milk Powder market size was valued at US$ 4013 million in 2024 and is forecast to a readjusted size of USD 8184 million by 2031 with a CAGR of 11.2% during review period.
HMO Children's Milk Powder refers to infant and toddler formula that contains Human Milk Oligosaccharides (HMOs), which are complex carbohydrates naturally found in human breast milk. HMOs play a vital role in the development of a baby’s immune system, gut microbiome, and overall health. These oligosaccharides are not fully digestible by infants but instead act as prebiotics, promoting the growth of beneficial gut bacteria. HMOs are important in strengthening the immune system and protecting infants from infections by fostering a healthy gut flora.
The range of HMO Children's Milk Powder includes products formulated to meet the nutritional needs of different stages of infant and toddler growth, typically broken down into three main categories:
Stage 1 (0-6 months): This formula is designed to mimic the nutritional composition of breast milk, providing essential nutrients like protein, fats, carbohydrates, vitamins, and minerals for optimal growth in newborns.
Stage 2 (6-12 months): As infants begin to consume solid foods, this formula continues to support development by providing additional nutrients needed for their growing bodies and developing immune systems.
Stage 3 (12+ months): This formula is tailored to meet the needs of toddlers as they transition to a more varied diet, offering higher energy content, added vitamins, and minerals to support continued growth, immune defense, and cognitive development.
HMO is now being integrated into a variety of baby formula products, and some brands may offer products that contain specific types of HMOs like 2'-fucosyllactose (2'-FL), which has been particularly studied for its health benefits. These formulas are often marketed as "closer to breast milk" to appeal to parents looking for premium options that enhance infant health and well-being.
Market Development Opportunities: The global market for HMO Children's Milk Powder is expanding, driven by increasing awareness of the importance of early childhood nutrition. The demand for HMO-based formulas is especially high in regions with a rising middle class, such as China, India, and Southeast Asia. As parents become more conscious of the nutritional value of baby formula, they seek options that resemble the benefits of breast milk, making HMO-enhanced formulas appealing. Moreover, the rise in online retailing and e-commerce has facilitated greater market reach for premium baby food brands, further boosting demand.
Key Drivers:
Health Consciousness: Parents are becoming increasingly aware of the advantages of HMOs in supporting immune health, digestive health, and overall development in infants. This is driving the demand for premium, scientifically advanced formula products.
Advancements in Biotechnology: The development of new methods for synthesizing HMOs using fermentation and other biotechnological processes has made HMO inclusion more feasible in commercial products. This has allowed manufacturers to meet the growing demand for HMOs at a lower cost and with more consistent quality.
Growing Market of Working Mothers: As more women join the workforce, the demand for convenient, high-quality infant formula has risen. HMO children's milk powder is perceived as a suitable alternative to breastfeeding, offering essential nutrients to babies in a way that supports immune function and gut health.
Risks:
Regulatory Challenges: The HMO-based formula market faces stringent regulations in various countries, especially concerning the health claims manufacturers make about these products. Compliance with local and international standards can be challenging and costly.
Supply Chain Constraints: The production of HMOs is still limited by the availability of raw materials and the cost of manufacturing through biotechnological processes. Supply chain disruptions or raw material shortages can impact product availability and cost.
Consumer Skepticism: While HMO-based formulas are often marketed as “closer to breast milk,” some parents may remain skeptical about the long-term effects and benefits of HMOs. Additionally, concerns about the ethical implications of infant formula marketing continue to exist, especially regarding aggressive advertising practices.
Market Concentration: The market for HMO Children's Milk Powder is currently dominated by a few major players, including global infant formula brands like Nestlé, Danone, Abbott, and FrieslandCampina. These companies are investing heavily in research and development to incorporate advanced nutritional ingredients such as HMOs into their product lines. Although the market is competitive, large multinational companies hold a significant share due to their established distribution networks, consumer trust, and brand recognition. However, smaller, specialized brands are also emerging, offering niche products tailored to specific needs, which helps to diversify the market.
Downstream Demand Trends: The demand for HMO Children’s Milk Powder is growing across several regions due to shifting consumer preferences towards products with perceived added health benefits. Parents are increasingly looking for formulas that support immune development, cognitive function, and digestive health, leading to a rise in premium and specialized formulas. Additionally, the demand for organic, non-GMO, and clean-label products is on the rise, which has created new opportunities for HMO-based formula products that align with these trends.
Latest Technologies: The incorporation of HMO into baby formulas has been significantly enhanced by advancements in biotechnology. Fermentation technologies have made the production of HMOs more scalable, affordable, and efficient. Research into specific types of HMOs, such as 2'-fucosyllactose (2'-FL), has revealed their positive effects on the gut microbiome and immune health. Additionally, innovations in nanotechnology and encapsulation techniques are helping improve the bioavailability of HMOs in baby formulas, ensuring that infants can derive maximum benefit from the ingredients. Manufacturers are also exploring novel ways to combine HMOs with other functional ingredients like probiotics and prebiotics to create even more comprehensive products.
In conclusion, the market for HMO Children’s Milk Powder presents significant opportunities, particularly as the demand for premium baby formulas grows globally. However, manufacturers must navigate regulatory complexities, manage production challenges, and adapt to evolving consumer preferences to remain competitive in this fast-evolving market.
This report is a detailed and comprehensive analysis for global HMO Children's Milk Powder market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global HMO Children's Milk Powder market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global HMO Children's Milk Powder market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global HMO Children's Milk Powder market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global HMO Children's Milk Powder market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for HMO Children's Milk Powder
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global HMO Children's Milk Powder market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Mead Johnson (Reckitt), Nestlé, Danone, FrieslandCampina(Friso), Yili Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
HMO Children's Milk Powder market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
2'-FL
Others
Market segment by Application
Online Channel
Specialty Store
Supermarket
Others
Major players covered
Abbott
Mead Johnson (Reckitt)
Nestlé
Danone
FrieslandCampina(Friso)
Yili Group
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe HMO Children's Milk Powder product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of HMO Children's Milk Powder, with price, sales quantity, revenue, and global market share of HMO Children's Milk Powder from 2020 to 2025.
Chapter 3, the HMO Children's Milk Powder competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the HMO Children's Milk Powder breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and HMO Children's Milk Powder market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of HMO Children's Milk Powder.
Chapter 14 and 15, to describe HMO Children's Milk Powder sales channel, distributors, customers, research findings and conclusion.
HMO Children's Milk Powder refers to infant and toddler formula that contains Human Milk Oligosaccharides (HMOs), which are complex carbohydrates naturally found in human breast milk. HMOs play a vital role in the development of a baby’s immune system, gut microbiome, and overall health. These oligosaccharides are not fully digestible by infants but instead act as prebiotics, promoting the growth of beneficial gut bacteria. HMOs are important in strengthening the immune system and protecting infants from infections by fostering a healthy gut flora.
The range of HMO Children's Milk Powder includes products formulated to meet the nutritional needs of different stages of infant and toddler growth, typically broken down into three main categories:
Stage 1 (0-6 months): This formula is designed to mimic the nutritional composition of breast milk, providing essential nutrients like protein, fats, carbohydrates, vitamins, and minerals for optimal growth in newborns.
Stage 2 (6-12 months): As infants begin to consume solid foods, this formula continues to support development by providing additional nutrients needed for their growing bodies and developing immune systems.
Stage 3 (12+ months): This formula is tailored to meet the needs of toddlers as they transition to a more varied diet, offering higher energy content, added vitamins, and minerals to support continued growth, immune defense, and cognitive development.
HMO is now being integrated into a variety of baby formula products, and some brands may offer products that contain specific types of HMOs like 2'-fucosyllactose (2'-FL), which has been particularly studied for its health benefits. These formulas are often marketed as "closer to breast milk" to appeal to parents looking for premium options that enhance infant health and well-being.
Market Development Opportunities: The global market for HMO Children's Milk Powder is expanding, driven by increasing awareness of the importance of early childhood nutrition. The demand for HMO-based formulas is especially high in regions with a rising middle class, such as China, India, and Southeast Asia. As parents become more conscious of the nutritional value of baby formula, they seek options that resemble the benefits of breast milk, making HMO-enhanced formulas appealing. Moreover, the rise in online retailing and e-commerce has facilitated greater market reach for premium baby food brands, further boosting demand.
Key Drivers:
Health Consciousness: Parents are becoming increasingly aware of the advantages of HMOs in supporting immune health, digestive health, and overall development in infants. This is driving the demand for premium, scientifically advanced formula products.
Advancements in Biotechnology: The development of new methods for synthesizing HMOs using fermentation and other biotechnological processes has made HMO inclusion more feasible in commercial products. This has allowed manufacturers to meet the growing demand for HMOs at a lower cost and with more consistent quality.
Growing Market of Working Mothers: As more women join the workforce, the demand for convenient, high-quality infant formula has risen. HMO children's milk powder is perceived as a suitable alternative to breastfeeding, offering essential nutrients to babies in a way that supports immune function and gut health.
Risks:
Regulatory Challenges: The HMO-based formula market faces stringent regulations in various countries, especially concerning the health claims manufacturers make about these products. Compliance with local and international standards can be challenging and costly.
Supply Chain Constraints: The production of HMOs is still limited by the availability of raw materials and the cost of manufacturing through biotechnological processes. Supply chain disruptions or raw material shortages can impact product availability and cost.
Consumer Skepticism: While HMO-based formulas are often marketed as “closer to breast milk,” some parents may remain skeptical about the long-term effects and benefits of HMOs. Additionally, concerns about the ethical implications of infant formula marketing continue to exist, especially regarding aggressive advertising practices.
Market Concentration: The market for HMO Children's Milk Powder is currently dominated by a few major players, including global infant formula brands like Nestlé, Danone, Abbott, and FrieslandCampina. These companies are investing heavily in research and development to incorporate advanced nutritional ingredients such as HMOs into their product lines. Although the market is competitive, large multinational companies hold a significant share due to their established distribution networks, consumer trust, and brand recognition. However, smaller, specialized brands are also emerging, offering niche products tailored to specific needs, which helps to diversify the market.
Downstream Demand Trends: The demand for HMO Children’s Milk Powder is growing across several regions due to shifting consumer preferences towards products with perceived added health benefits. Parents are increasingly looking for formulas that support immune development, cognitive function, and digestive health, leading to a rise in premium and specialized formulas. Additionally, the demand for organic, non-GMO, and clean-label products is on the rise, which has created new opportunities for HMO-based formula products that align with these trends.
Latest Technologies: The incorporation of HMO into baby formulas has been significantly enhanced by advancements in biotechnology. Fermentation technologies have made the production of HMOs more scalable, affordable, and efficient. Research into specific types of HMOs, such as 2'-fucosyllactose (2'-FL), has revealed their positive effects on the gut microbiome and immune health. Additionally, innovations in nanotechnology and encapsulation techniques are helping improve the bioavailability of HMOs in baby formulas, ensuring that infants can derive maximum benefit from the ingredients. Manufacturers are also exploring novel ways to combine HMOs with other functional ingredients like probiotics and prebiotics to create even more comprehensive products.
In conclusion, the market for HMO Children’s Milk Powder presents significant opportunities, particularly as the demand for premium baby formulas grows globally. However, manufacturers must navigate regulatory complexities, manage production challenges, and adapt to evolving consumer preferences to remain competitive in this fast-evolving market.
This report is a detailed and comprehensive analysis for global HMO Children's Milk Powder market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global HMO Children's Milk Powder market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global HMO Children's Milk Powder market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global HMO Children's Milk Powder market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global HMO Children's Milk Powder market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for HMO Children's Milk Powder
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global HMO Children's Milk Powder market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Mead Johnson (Reckitt), Nestlé, Danone, FrieslandCampina(Friso), Yili Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
HMO Children's Milk Powder market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
2'-FL
Others
Market segment by Application
Online Channel
Specialty Store
Supermarket
Others
Major players covered
Abbott
Mead Johnson (Reckitt)
Nestlé
Danone
FrieslandCampina(Friso)
Yili Group
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe HMO Children's Milk Powder product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of HMO Children's Milk Powder, with price, sales quantity, revenue, and global market share of HMO Children's Milk Powder from 2020 to 2025.
Chapter 3, the HMO Children's Milk Powder competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the HMO Children's Milk Powder breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and HMO Children's Milk Powder market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of HMO Children's Milk Powder.
Chapter 14 and 15, to describe HMO Children's Milk Powder sales channel, distributors, customers, research findings and conclusion.
Table of Contents
104 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: HMO Children's Milk Powder by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
